Cargando…

Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination

BACKGROUND: Antibodies to the myelin oligodendrocyte glycoprotein (MOG) are associated with a subset of inflammatory demyelinating diseases of the central nervous system such as acute disseminated encephalomyelitis and neuromyelitis optica spectrum disorders. However, whether human MOG antibodies ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peschl, Patrick, Schanda, Kathrin, Zeka, Bleranda, Given, Katherine, Böhm, Denise, Ruprecht, Klemens, Saiz, Albert, Lutterotti, Andreas, Rostásy, Kevin, Höftberger, Romana, Berger, Thomas, Macklin, Wendy, Lassmann, Hans, Bradl, Monika, Bennett, Jeffrey L., Reindl, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657084/ https://www.ncbi.nlm.nih.gov/pubmed/29070051 http://dx.doi.org/10.1186/s12974-017-0984-5

Ejemplares similares

Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases
por: Peschl, Patrick, et al.
Publicado: (2017)

Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases
por: Hofer, Livia Sophie, et al.
Publicado: (2020)

Diagnostic challenges and pitfalls of myelin oligodendrocyte glycoprotein antibody–associated demyelination: Lessons from neuropathology
por: Höftberger, Romana, et al.
Publicado: (2019)

More Efficient Complement Activation by Anti–Aquaporin-4 Compared With Anti–Myelin Oligodendrocyte Glycoprotein Antibodies
por: Lerch, Magdalena, et al.
Publicado: (2022)

The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody
por: Höftberger, Romana, et al.
Publicado: (2020)

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
por: Mader, Simone, et al.
Publicado: (2011)

NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases
por: Ramberger, Melanie, et al.
Publicado: (2015)

Müller cells and retinal axons can be primary targets in experimental neuromyelitis optica spectrum disorder
por: Zeka, Bleranda, et al.
Publicado: (2017)

Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder
por: Bauer, Angelika, et al.
Publicado: (2022)

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
por: Jarius, Sven, et al.
Publicado: (2020)

Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination
por: Liu, Yiting, et al.
Publicado: (2017)

Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
por: Tea, Fiona, et al.
Publicado: (2019)

Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord
por: Oji, Satoru, et al.
Publicado: (2016)

Comparison of Diagnostic Accuracy of Microscopy and Flow Cytometry in Evaluating N-Methyl-D-Aspartate Receptor Antibodies in Serum Using a Live Cell-Based Assay
por: Ramberger, Melanie, et al.
Publicado: (2015)

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients
por: Jarius, Sven, et al.
Publicado: (2020)

Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases
por: Schanda, Kathrin, et al.
Publicado: (2021)

Intractable Hiccup in Demyelinating Disease with Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Akaishi, Tetsuya, et al.
Publicado: (2016)

Impaired Brain Growth in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Acute Disseminated Encephalomyelitis
por: Bartels, Frederik, et al.
Publicado: (2023)

The Potential Pathogenicity of Myelin Oligodendrocyte Glycoprotein Antibodies in the Optic Pathway
por: Lerch, Magdalena, et al.
Publicado: (2023)

Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology
por: Di Pauli, Franziska, et al.
Publicado: (2015)

Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study
por: Oertel, Frederike C., et al.
Publicado: (2019)

Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD
por: Zeka, Bleranda, et al.
Publicado: (2016)

Methodological Challenges in Protein Microarray and Immunohistochemistry for the Discovery of Novel Autoantibodies in Paediatric Acute Disseminated Encephalomyelitis
por: Peschl, Patrick, et al.
Publicado: (2017)

Antibody-mediated biorecognition of myelin oligodendrocyte glycoprotein: computational evidence of demyelination-related epitopes
por: Ierich, Jéssica Cristiane Magalhães, et al.
Publicado: (2019)

MRI-Negative Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Antibody Spectrum Demyelinating Disease
por: Pérez, Carlos A., et al.
Publicado: (2019)

Serial Anti–Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes
por: Waters, Patrick, et al.
Publicado: (2019)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Varicella Zoster Virus Infection - Frequency of an Association
por: Di Pauli, Franziska, et al.
Publicado: (2021)

Inflammatory demyelinating diseases of the central nervous system
por: Höftberger, Romana, et al.
Publicado: (2018)

Oligodendrocytes: biology and pathology
por: Bradl, Monika, et al.
Publicado: (2009)

Progressive Demyelination in the Presence of Serum Myelin Oligodendrocyte Glycoprotein-IgG: A Case Report
por: Gil-Perotin, Sara, et al.
Publicado: (2018)

CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies
por: Zhao-Fleming, Hannah H., et al.
Publicado: (2021)

Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status
por: S, Mariotto, et al.
Publicado: (2017)

Myelin Oligodendrocyte Glycoprotein (MOG)-IgG Associated Demyelinating Disease: Our Experience with this Distinct Syndrome
por: Pujari, Shripad S., et al.
Publicado: (2021)

Serum Neurofilament Light Chain Levels and Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Acquired Demyelinating Syndromes
por: Simone, Marta, et al.
Publicado: (2021)

Frequency of myelin oligodendrocyte glycoprotein antibodies in a large cohort of neurological patients
por: Held, Friederike, et al.
Publicado: (2021)

Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat
por: Hillebrand, Sophie, et al.
Publicado: (2018)

Dissection of complement and Fc-receptor-mediated pathomechanisms of autoantibodies to myelin oligodendrocyte glycoprotein
por: Mader, Simone, et al.
Publicado: (2023)

Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis
por: Elong Ngono, Annie, et al.
Publicado: (2015)

Guilty by association? SARS‐CoV‐2 antibodies and myelin oligodendrocyte glycoprotein antibody‐associated disease
por: Tanasescu, Radu, et al.
Publicado: (2022)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?
por: Di Pauli, Franziska, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eme99jj0uvdbk3ttdrfhp75itb